Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMGHXQE)

Drug Name
AMX-256 Drug Info
Synonyms GLP-2 (XTEN formulation, Crohns disease), Amunix; GLP-2 (XTEN formulation, Crohns disease/short bowel syndrome), Amunix
Indication
Disease Entry ICD 11 Status REF
Short bowel syndrome KB89.1 Investigative [1]
Cross-matching ID
TTD Drug ID
DMGHXQE

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Glucagon-like peptide 2 receptor (GLP2R)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Teduglutide DMYOAKS Short bowel syndrome KB89.1 Approved [2]
Elsiglutide DMB7CPG Diarrhea ME05.1 Phase 2 [3]
SAN-134 DMWU71N Osteoporosis FB83.0 Phase 1 [4]
ZP-1848 DMGTL8Z Inflammatory bowel disease DD72 Phase 1 [5]
FE-203799 DMBX81R Gastrointestinal disease DE2Z Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Glucagon-like peptide 2 receptor (GLP2R) TT1YWO5 GLP2R_HUMAN Modulator [1]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 250).
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 Poster Abstracts. Volume 10, Issue Supplement S8, pages 126-209, December 2014.
4 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020865)
5 US patent application no. 8,580,918, Peptidic glp-2 agonists.